| 000 | 01199 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516093847.0 | ||
| 264 | 0 | _c20120904 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1420-9071 | ||
| 024 | 7 |
_a10.1007/s00018-012-1014-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSorce, Silvia | |
| 245 | 0 | 0 |
_aTargeting NOX enzymes in the central nervous system: therapeutic opportunities. _h[electronic resource] |
| 260 |
_bCellular and molecular life sciences : CMLS _cJul 2012 |
||
| 300 |
_a2387-407 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCentral Nervous System Diseases _xenzymology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNADPH Oxidases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Isoforms _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSmall Molecule Libraries _xchemical synthesis |
| 700 | 1 | _aKrause, Karl-Heinz | |
| 700 | 1 | _aJaquet, Vincent | |
| 773 | 0 |
_tCellular and molecular life sciences : CMLS _gvol. 69 _gno. 14 _gp. 2387-407 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00018-012-1014-5 _zAvailable from publisher's website |
| 999 |
_c21819620 _d21819620 |
||